Folic Acid-Functionalized Albumin/Graphene Oxide Nanocomposite to Simultaneously Deliver Curcumin and 5-Fluorouracil into Human Colorectal Cancer Cells: An In Vitro Study

BACKGROUND: Nowadays, due to various inherent properties, graphene-based nanoparticles are widely used in drug delivery research.

On the other hand, folate receptors are highly expressed on the surface of human tumor cells.

In this work, to enhance the 5-fluorouracil (5FU) and curcumin (Cur) effects on colon cancer, we constructed a folic acid- (FA-) modified codelivery carrier based on graphene nanoparticles (GO-Alb-Cur-FA-5FU).

MATERIALS AND METHODS: The HUVEC and HT-29 were selected for evaluating the antitumor effect of the prepared nanocarriers.

The structure of nanocarriers was characterized by FTIR spectroscopy, X-ray diffraction analysis, TEM microscopy, and a DLS analyzer.

The efficiency of the prepared carrier was evaluated by fluorescence microscopy using Annexin V and the PI kit.

The cytotoxicity of the carrier's component individually and the efficacy of the drug carrier GO-Alb-Cur-FA-5FU were assessed by MTT.

RESULTS: The results of the pharmacological tests indicated that the new nanoparticles cause increased apparent toxicity in HT-29 cells.

The apoptosis rate of the HT-29 and HUVEC cells treated with IC50 values of GO-Alb-Cur-FA-5FU for 48 h was higher than the cells treated with IC50 values of 5FU and Cur individually, which indicated the greater inhibitory efficacy of GO-Alb-Cur-FA-5FU than free drugs.

CONCLUSION: The designed GO-Alb-CUR-FA-5FU delivery system can be applied for targeting colon cancer cells and can be severe as a potential candidate for future drug development.